# Effect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery: A Risk-Stratified Randomized Controlled Trial.

> **NCT07140640** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Aswan University** · enrollment: 333 (estimated)

## Conditions studied

- Cesarean Section Complications

## Interventions

- **DRUG:** Hyperbaric Bupivacaine HCl 0.5% 12.5 mg
- **DRUG:** Hyperbaric Bupivacaine HCl 0.5% 10 mg

## Key facts

- **NCT ID:** NCT07140640
- **Lead sponsor:** Aswan University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-15
- **Primary completion:** 2026-03-15
- **Final completion:** 2026-03-30
- **Target enrollment:** 333 (ESTIMATED)
- **Last updated:** 2025-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07140640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07140640, "Effect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery: A Risk-Stratified Randomized Controlled Trial.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07140640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*